New probiotics: Dairy propionibacteria and the modulation of gut microbiota and physiology

Interactive Probiotics

Volumn , Issue , 2014, Pages 122-147

  Deutsch, Stéphanie Marie ^a   Jan, Gwénaël ^a  

^a UMR1253   (France)

Author keywords

Apoptosis; Cancer; Colitis; Colon; Immunomodulation; In vitro studies; In vivo studies; Interleukines; Probiotic propionibacterium; Short chain fatty acids

Indexed keywords

EID: 84944161673     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b16439     Document Type: Chapter

References (137)

1. Adams, M.C. and Y. Huang. 2003. Probiotic Propionibacterium jensenii 702. Australia, University of Newcastle Research Associates Ltd. [WO2004001022-A1]. Ref Type: Patent
2. Adams, M.C. and Y. Huang. 2008. Probiotic Propionibacterium. University of Newcastle Research Associates Ltd. [US 07427397]. Ref Type: Patent
3. Adams, M.C., M.L. Lean, N.C. Hitchick and K.W. Beagley. 2005. The effi cacy of Propionibacterium jensenii 702 to stimulate a cell-mediated response to orally administered soluble Mycobacterium tuberculosis antigens using a mouse model. Lait 85: 75-84.
4. Alvarez, S., M. Medici, E. Vintini, G. Oliver, A.P. de Ruiz Holgado and G. Perdigon. 1996. Effect of the oral administration of Propionibacterium acidi-propionici on IgA levels and on the prevention of enteric infection in mice. Microbiol. Alim. Nutr. 14: 237-243.
5. Anastasiou, R., P. Leverrier, I. Krestas, A. Rouault, G. Kalantzopoulos, P. Boyaval, E. Tsakalidou and G. Jan. 2006. Changes in protein synthesis during thermal adaptation of Propionibacterium freudenreichii subsp. shermanii. Int. J. Food Microbiol. 108: 301-314.
6. Andresen, L., K.A. Hansen, H. Jensen, S.F. Pedersen, P. Stougaard, H.R. Hansen, J. Jurlander and S. Skov. 2009. Propionic Acid Secreted from Propionibacteria Induces NKG2D Ligand Expression on Human-Activated T Lymphocytes and Cancer Cells. Journal of Immunology 183: 897-906.
7. Bouglé, D., N. Roland, F. Lebeurrier and P. Arhan. 1999. Effect of propionibacteria supplementation on fecal bifi dobacteria and segmental colonic transit time in healthy human subjects. Scand. J. Gastroenterol. 34: 144-148.
8. Bouglé, D., N. Vaghefi -Vaezzadeh, N. Roland, G. Bouvard, P. Arhan, F. Bureau, D. Neuville and J.L. Maubois. 2002. Infl uence of short-chain fatty acids on iron absorption by proximal colon. Scandinavian Journal of Gastroenterology 37: 1008-1011.
9. Boyaval, P., C. Deborde, C. Corre, C. Blanco and E. Begue. 1999. Stress and osmoprotection in propionibacteria. Lait 79: 59-69.
10. Brzuszkiewicz, E., J. Weiner, A. Wollherr, A. Thurmer, J. Hupeden, H.B. Lomholt, M. Kilian, G. Gottschalk, R. Daniel, H.J. Mollenkopf, T.F. Meyer and H. Bruggemann. 2011. Comparative genomics and transcriptomics of Propionibacterium acnes. PLoS. ONE. 6: e21581.
11. Cardoso, F.S., P. Gaspar, J. Hugenholtz, A. Ramos and H. Santos. 2004. Enhancement of trehalose production in dairy propionibacteria through manipulation of environmental conditions. Int. J. Food Microbiol. 91: 195-204.
12. Clark, J.E., H. Beegen and H.G. Wood. 1986. Isolation of intact chains of polyphosphate from “Propionibacterium shermanii” grown on glucose or lactate. J. Bacteriol. 168: 1212-1219.
13. Clayton, J.J., W. Baig, G.W. Reynolds and J.A. Sandoe. 2006. Endocarditis caused by Propionibacterium species: a report of three cases and a review of clinical features and diagnostic diffi culties. J. Med. Microbiol. 55: 981-987.
14. Collado, M.C., L. Jalonen, J. Meriluoto and S. Salminen. 2006. Protection mechanism of probiotic combination against human pathogens: in vitro adhesion to human intestinal mucus. Asia Pac. J. Clin. Nutr. 15: 570-575.
15. Collado, M.C., J. Meriluoto and S. Salminen. 2007. In vitro analysis of probiotic strain combinations to inhibit pathogen adhesion to human intestinal mucus. Food Res. Int. 40: 629-636.
16. Collado, M.C., J. Meriluoto and S. Salminen. 2007. Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus. Lett. Appl. Microbiol. 45: 454-460.
17. Collado, M.C., J. Meriluoto and S. Salminen. 2008. Adhesion and aggregation properties of probiotic and pathogen strains. Eur. Food Res. Technol. 226: 1065-1073.
18. Colomban, A., L. Roger and P. Boyaval. 1993. Production of propionic acid from whey permeate by sequential fermentation, ultrafi ltration, and cell recycling. Biotechnol. Bioeng. 42: 1091-1098.
19. Cousin, F.J., S.M. Deutsch, A. Perez Chaia, B. Foligné and G. Jan. 2012. Interactions between probiotic dairy propionibacteria and the intestinal epithelium. Curr. Immunol. Rev. 8: 216-226.
20. Cousin, F.J., B. Foligne, S.M. Deutsch, S. Massart, S. Parayre, Y. Le Loir, G. Boudry and G. Jan. 2012. Assessment of the probiotic potential of a dairy product fermented by Propionibacterium freudenreichii in piglets. J. Agric. Food Chem. 60: 7917-7927.
21. Cousin, F.J., S. Jouan-Lanhouet, M.T. Dimanche-Boitrel, L. Corcos and G. Jan. 2012. Milk Fermented by Propionibacterium freudenreichii Induces Apoptosis of HGT-1 Human Gastric Cancer Cells. PLoS. ONE. 7: e31892.
22. Cousin, F.J., S. Louesdon, M.B. Maillard, S. Parayre, H. Falentin, S.M. Deutsch, G. Boudry and G. Jan. 2012. The fi rst dairy product exclusively fermented by Propionibacterium freudenreichii: a new vector to study probiotic potentialities in vivo. Food Microbiol. 32: 135-146.
23. Cousin, F.J., D. Mater, B. Foligné and G. Jan. 2011. Dairy propionibacteria as human probiotics: A review of recent evidence. Dairy Sci. Technol. 91: 1-26.
24. Crittenden, R.G., N.R. Martinez and M.J. Playne. 2003. Synthesis and utilisation of folate by yoghurt starter cultures and probiotic bacteria. Int. J. Food Microbiol. 80: 217-222.
25. Cummings, C.S. and J.L. Johnson. 1992. The genus Propionibacterium. In: The prokaryotes. E. Balows, H.G. Truper, M. Dworkin, W. Harder, K.H. Schleifer [eds.]. Vol I, Springer- Verlag, Chapitre.
26. Cummins, C.S. and J.L. Johnson. 1986. Genus I. Propionibacterium Orla-Jensen. 1909. In Bergey’s Manual of Systematic Bacteriology (Baltimore: Williams & Wilkins), pp. 1346-1353.
27. Dalmasso, M., J. Aubert, S. Even, H. Falentin, M.B. Maillard, S. Parayre, V. Loux, J. Tanskanen and A. Thierry. 2012. Accumulation of intracellular glycogen and trehalose by Propionibacterium freudenreichii under conditions mimicking cheese ripening in the cold. Appl. Environ. Microbiol. 78: 6357-6364.
28. Deborde, C. 2002. Propionibacterium spp. In: Encyclopedia of Dairy Sciences, H.Roginski, J.W. Fuquay and P.F. Fox [eds.]. Kent, UK: Academic Press, Elsevier Science, pp. 2330-2339.
29. Deborde, C., C. Corre, D.B. Rolin, L. Nadal, J.D. de Certaines and P. Boyaval. 1996. Trehalose biosynthesis in dairy Propionibacterium. J. Magn. Res. Anal. 2 297-304: -30444.
30. Deutsch, S.M., S. Parayre, A. Bouchoux, F. Guyomarc’h, J. Dewulf, M. Dols-Lafargue, F. Baglinière, F.J. Cousin, H. Falentin, G. Jan and B. Foligné. 2012. Contribution of surface beta-glucan polysaccharide to physicochemical and immunomodulatory properties of Propionibacterium freudenreichii. Appl. Environ. Microbiol. 78: 1765-1775.
31. Dherbecourt, J., H. Falentin, J. Jardin, M.B. Maillard, F. Bagliniere, F. Barloy-Hubler and A. Thierry. 2010. Identifi cation of a secreted lipolytic esterase in Propionibacterium freudenreichii, a ripening process bacterium involved in Emmental cheese lipolysis. Appl. Environ. Microbiol. 76: 1181-1188.
32. Dherbecourt, J., M.B. Maillard, D. Catheline and A. Thierry. 2008. Production of branchedchain aroma compounds by Propionibacterium freudenreichii: links with the biosynthesis of membrane fatty acids. J. Appl. Microbiol. 105: 977-985.
33. El-Nezami, H., P. Kankaanpaa, S. Salminen and J. Ahokas. 1998. Ability of dairy strains of lactic acid bacteria to bind a common food carcinogen, afl atoxin B-1. Food and Chemical Toxicology 36: 321-326.
34. El-Nezami, H., H. Mykkanen, P. Kankaanpaa, T. Suomalainen, S. Salminen and J. Ahokas. 2000. Ability of a mixture of Lactobacillus and Propionibacterium to infl uence the faecal afl atoxin content in healthy Egyptian volunteers: a pilot clinical study. Biosci. Microfl. 19: 41-45.
35. El-Nezami, H.S., A. Chrevatidis, S. Auriola, S. Salminen and H. Mykkanen. 2002. Removal of common Fusarium toxins in vitro by strains of Lactobacillus and Propionibacterium. Food Addit. Contam. 19: 680-686.
36. El-Nezami, H.S., N.N. Polychronaki, J. Ma, H. Zhu, W. Ling, E.K. Salminen, R.O. Juvonen, S.J. Salminen, T. Poussa and H.M. Mykkanen. 2006. Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China. Am. J. Clin. Nutr. 83: 1199-1203.
37. Falentin, H., S.M. Deutsch, G. Jan, V. Loux, A. Thierry, S. Parayre, M.B. Maillard, J. Dherbecourt, F.J. Cousin, J. Jardin, P. Siguier, A. Couloux, V. Barbe, B. Vacherie, P. Wincker, J.F. Gibrat, C. Gaillardin and S. Lortal. 2010. The complete genome of Propionibacterium freudenreichii CIRM-BIA1, a hardy actinobacterium with food and probiotic applications. PLoS. ONE. 5: e11748.
38. Foligné, B., S.M. Deutsch, J. Breton, F.J. Cousin, J. Dewulf, M. Samson, B. Pot and G. Jan. 2010. Promising immunomodulatory effects of selected strains of dairy propionibacteria as evidenced in vitro and in vivo. Appl. Environ. Microbiol. 76: 8259-8264.
39. Foligné, B., S. Nutten, C. Grangette, V. Dennin, D. Goudercourt, S. Poiret, J. Dewulf, D. Brassart, A. Mercenier and B. Pot. 2007. Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J. Gastroenterol. 13: 236-243.
40. Fukushima, A., Y. Aizaki and K. Sakuma. 2009. Short-chain fatty acids induce intestinal transient receptor potential vanilloid type 6 expression in rats and Caco-2 cells. J. Nutr. 139: 20-25.
41. Furuichi, K., K. Hojo, Y. Katakura, K. Ninomiya and S. Shioya. 2006. Aerobic culture of Propionibacterium freudenreichii ET-3 can increase production ratio of 1,4-dihydroxy-2- naphthoic acid to menaquinone. J. Biosci. Bioeng. 101: 464-470.
42. Gratz, S., H. Mykkanen and H. El Nezami. 2005. Afl atoxin B1 binding by a mixture of Lactobacillus and Propionibacterium: in vitro versus ex vivo. J Food Prot 68: 2470-2474.
43. Halttunen, T., M.C. Collado, H. El-Nezami, J. Meriluoto and S. Salminen. 2008. Combining strains of lactic acid bacteria may reduce their toxin and heavy metal removal effi ciency from aqueous solution. Lett. Appl. Microbiol. 46: 160-165.
44. Hartemink, R. and F.M. Rombouts. 1999. Comparison of media for the detection of bifi dobacteria, lactobacilli and total anaerobes from faecal samples. J. Microbiol. Meth. 36: 181-192.
45. Haskard, C.A., H.S. El-Nezami, P.E. Kankaanpaa, S. Salminen and J.T. Ahokas. 2001. Surface binding of afl atoxin B(1) by lactic acid bacteria. Appl. Environ. Microbiol. 67: 3086-3091.
46. Hatakka, K., R. Holma, H. El-Nezami, T. Suomalainen, M. Kuisma, M. Saxelin, T. Polussa, H. Mykkanen and R. Korpela. 2008. The infl uence of Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp. shermanii JS on potentially carcinogenic bacterial activity in human colon. Int. J. Food Microbiol. 128: 406-410.
47. Hervé, C., M. Fondrevez, A. Cheron, F. Barloy-Hubler and G. Jan. 2007. Transcarboxylase mRNA: a marker which evidences P. freudenreichii survival and metabolic activity during its transit in the human gut. Int. J. Food Microbiol. 113: 303-314.
48. Hojo, K., N. Yoda, H. Tsuchita, T. Ohtsu, K. Seki, N. Taketomo, T. Murayama and H. Lino. 2002. Effect of ingested culture of Propionibacterium freudenreichii ET-3 on fecal microfl ora and stool frequency in healthy females. Biosci. Microfl. 21: 115-120.
49. Huang, Y. and M.C. Adams. 2004. In vitro assessment of the upper gastrointestinal tolerance of potential probiotic dairy propionibacteria. Int. J. Food Microbiol. 91: 253-260.
50. Hugenholtz, J., J. Hunik, H. Santos and E. Smid. 2002. Nutraceutical production by propionibacteria. Lait 82: 103-112.
51. Ibrahim, F., T. Halttunen, R. Tahvonen and S. Salminen. 2006. Probiotic bacteria as potential detoxifi cation tools: assessing their heavy metal binding isotherms. Can. J. Microbiol. 52: 877-885.
52. Isawa, K., K. Hojo, N. Yoda, T. Kamiyama, S. Makino, M. Saito, H. Sugano, C. Mizoguchi, S. Kurama, M. Shibasaki, N. Endo and Y. Sato. 2002. Isolation and identifi cation of a new bifi dogenic growth stimulator produced by Propionibacterium freudenreichii ET-3. Bioscience Biotechnology and Biochemistry 66: 679-681.
53. Jakab, E., R. Zbinden, J. Gubler, C. Ruef, G. A. von and M. Krause. 1996. Severe infections caused by Propionibacterium acnes: an underestimated pathogen in late postoperative infections. Yale J. Biol. Med. 69: 477-482.
54. Jan, G., A.S. Belzacq, D. Haouzi, A. Rouault, D. Metivier, G. Kroemer and C. Brenner. 2002a. Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria. Cell Death Differ. 9: 179-188.
55. Jan, G., P. Leverrier, V. Pichereau and P. Boyaval. 2001. Changes in protein synthesis and morphology during acid adaptation of Propionibacterium freudenreichii. Appl. Environ. Microbiol. 67: 2029-2036.
56. Jan, G., P. Leverrier and N. Roland. 2002b. Survival and benefi cial effects of propionibacteria in the human gut: in vivo and in vitro investigations. Lait 82: 131-144.
57. Jan, G., A. Rouault and J.L. Maubois. 2000. Acid stress susceptibility and acid adaptation of Propionibacterium freudenreichii subsp. shermanii. Lait 80: 325-336.
58. Jiang, J., L. Bjorck and R. Fonden. 1998. Production of conjugated linoleic acid by dairy starter cultures. J Appl. Microbiol. 85: 95-102.
59. Kajander, K., L. Krogius-Kurikka, T. Rinttila, H. Karjalainen, A. Palva and R. Korpela. 2007. Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome. Aliment. Pharmacol. Ther. 26: 463-473.
60. Kaneko, T. 1999. A novel bifi dogenic growth stimulator produced by Propionibacterium freudenreichii. Biosci. Microfl. 18: 73-80.
61. Kaneko, T., H. Mori, M. Iwata and S. Meguro. 1994. Growth stimulator for bifi dobacteria produced by Propionibacterium freudenreichii and several intestinal bacteria. J. Dairy Sci. 77: 393-404.
62. Kekkonen, R.A., E. Kajasto, M. Miettinen, V. Veckman, R. Korpela and I. Julkunen. 2008. Probiotic Leuconostoc mesenteroides ssp. cremoris and Streptococcus thermophilus induce IL-12 and IFN-gamma production. World J. Gastroenterol. 14: 1192-1203.
63. Kekkonen, R.A., N. Lummela, H. Karjalainen, S. Latvala, S. Tynkkynen, S. Jarvenpaa, H. Kautiainen, I. Julkunen, H. Vapaatalo and R. Korpela. 2008. Probiotic intervention has strain-specifi c anti-infl ammatory effects in healthy adults. World J. Gastroenterol. 14: 2029-2036.
64. Kirjavainen, P.V., H.S. El Nezami, S.J. Salminen, J.T. Ahokas and P.F. Wright. 1999. Effects of orally administered viable Lactobacillus rhamnosus GG and Propionibacterium freudenreichii subsp. shermanii JS on mouse lymphocyte proliferation. Clin. Diagn. Lab. Immunol. 6: 799-802.
65. Kuitunen, M., K. Kukkonen, K. Juntunen-Backman, R. Korpela, T. Poussa, T. Tuure, T. Haahtela and E. Savilahti. 2009. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J. Allergy Clin. Immunol. 123: 335-341.
66. Kukkonen, K., E. Savilahti, T. Haahtela, K. Juntunen-Backman, R. Korpela, T. Poussa, T. Tuure and M. Kuitunen. 2007. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J. Allergy Clin. Immunol. 119: 192-198.
67. Kukkonen, K., E. Savilahti, T. Haahtela, K. Juntunen-Backman, R. Korpela, T. Poussa, T. Tuure and M. Kuitunen. 2008. Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebocontrolled trial. Pediatrics 122: 8-12.
68. Lan, A., A. Bruneau, M. Bensaada, C. Philippe, P. Bellaud, S. Rabot and G. Jan. 2008. Increased induction of apoptosis by Propionibacterium freudenreichii TL133 in colonic mucosal crypts of human microbiota-associated rats treated with 1,2-dimethylhydrazine. Br. J. Nutr. 100: 1251-1259.
69. Lan, A., D. Lagadic-Gossmann, C. Lemaire, C. Brenner and G. Jan. 2007. Acidic extracellular pH shifts colorectal cancer cell death from apoptosis to necrosis upon exposure to propionate and acetate, major end-products of the human probiotic propionibacteria. Apoptosis 12: 573-591.
70. Langsrud, T. and G.W. Reinbold. 1973. Flavor development and microbiology of Swiss cheese. A Review. III Ripening and fl avor production. J. Milk Food Technol. 36: 593-609.
71. Lavillonniere, F., V. Chajes, J.C. Martin, J.L. Sebedio, C. Lhuillery and P. Bougnoux. 2003. Dietary purifi ed cis-9, trans-11 conjugated linoleic acid isomer has anticarcinogenic properties in chemically induced mammary tumors in rats. Nutr. Cancer 45: 190-194.
72. LeBlanc, J.G., G. Rutten, P. Bruinenberg, F. Sesma, G.S. de Giori and E.J. Smid. 2006. A novel dairy product fermented with Propionibacterium freudenreichii improves the ribofl avin status of defi cient rats. Nutrition 22: 645-651.
73. Lee, Y.K., H. El-Nezami, C.A. Haskard, S. Gratz, K.Y. Puong, S. Salminen and H. Mykkanen. 2003. Kinetics of adsorption and desorption of afl atoxin B1 by viable and nonviable bacteria. J. Food Prot. 66: 426-430.
74. Leverrier, P., D. Dimova, V. Pichereau, Y. Auffray, P. Boyaval and G. Jan. 2003. Susceptibility and adaptive response to bile salts in Propionibacterium freudenreichii: physiological and proteomic analysis. Appl. Environ. Microbiol. 69: 3809-3818.
75. Leverrier, P., Y. Fremont, A. Rouault, P. Boyaval and G. Jan. 2005. In vitro tolerance to digestive stresses of propionibacteria: infl uence of food matrices. Food Microbiol. 22: 11-18.
76. Leverrier, P., J.P. Vissers, A. Rouault, P. Boyaval and G. Jan. 2004. Mass spectrometry proteomic analysis of stress adaptation reveals both common and distinct response pathways in Propionibacterium freudenreichii. Arch. Microbiol. 181: 215-230.
77. Lock, A.L., B.A. Corl, D.M. Barbano, D.E. Bauman and C. Ip. 2004. The anticarcinogenic effect of trans-11 18:1 is dependent on its conversion to cis-9, trans-11 CLA by delta9-desaturase in rats. J. Nutr. 134: 2698-2704.
78. Michel, C., N. Roland, G. Lecannu, C. Hervé, J.C. Avice, M. Rival and C. Cherbut. 2005. Colonic infusion with Propionibacterium acidipropionici reduces severity of chemically-induced colitis in rats. Lait 85: 99-111.
79. Mitsuyama, K., J. Masuda, H. Yamasaki, K. Kuwaki, S. Kitazaki, H. Koga, M. Uchida and M. Sata. 2007. Treatment of ulcerative colitis with milk whey culture with Propionibacterium freudenreichii. J. Intest. Microbiol. 21: 143-147.
80. Mocquot, G. 1979. Reviews of the progress of dairy science: Swiss-type cheese. J. Dairy Res. 46: 133-160.
81. Morata, D.A., V.S. Gonzalez, A.P. Ruiz Holgado and G. Oliver. 1998. Study of the morphology of the cell walls of some strains of lactic acid bacteria and related species. J. Food Prot. 61: 557-562.
82. Mori, H., Y. Sato, N. Taketomo, T. Kamiyama, Y. Yoshiyama, S. Meguro, H. Sato and T. Kaneko. 1997. Isolation and structural identifi cation of bifi dogenic growth stimulator produced by Propionibacterium freudenreichii. J. Dairy Sci. 80: 1959-1964.
83. Moussavi, M. and M.C. Adams. 2010. An in vitro study on bacterial growth interactions and intestinal epithelial cell adhesion characteristics of probiotic combinations. Curr. Microbiol. 60: 327-335.
84. Murooka, Y., Y. Piao, P. Kiatpapan and M. Yamashita. 2005. Production of tetrapyrrole compounds and vitamin B12 using genetically engineering of Propionibacterium freudenreichii. An overview. Lait 85: 9-22.
85. Myllyluoma, E., T. Ahlroos, L. Veijola, H. Rautelin, S. Tynkkynen and R. Korpela. 2007. Effects of anti-Helicobacter pylori treatment and probiotic supplementation on intestinal microbiota. Int. J. Antimicrob. Agents 29: 66-72.
86. Myllyluoma, E., A.M. Ahonen, R. Korpela, H. Vapaatalo and E. Kankuri. 2008. Effects of multispecies probiotic combination on Helicobacter pylori infection in vitro. Clinical and Vaccine Immunology 15: 1472-1482.
87. Myllyluoma, E., L. Veijola, T. Ahlroos, S. Tynkkynen, E. Kankuri, H. Vapaatalo, H. Rautelin and R. Korpela. 2005. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy-a placebo-controlled, double-blind randomized pilot study. Aliment. Pharmacol. Ther. 21: 1263-1272.
88. Niderkorn, V., H. Boudra and D.P. Morgavi. 2006. Binding of Fusarium mycotoxins by fermentative bacteria in vitro. J. Appl. Microbiol. 101: 849-856.
89. Okada, Y., R. Hokari, S. Kato, N. Mataki, K. Okudaira, K. Takebayashi, H. Matsunaga, Y. Tsuzuki, S. Komoto, C. Watanabe, A. Kawaguchi, S. Nagao, K. Itoh and S. Miura. 2006. 1.4-dihydroxy-2-naphthoic acid (DHNA) shows anti-infl ammatory effect on NSAID-induced colitis in IL-10-knockout mice through suppression of infl ammatory cell infi ltration and increased number of genus Bifi dobacterium. Gastroenterology 130: A313.
90. Okada, Y., Y. Tsuzuki, J. Miyazaki, K. Matsuzaki, R. Hokari, S. Komoto, S. Kato, A. Kawaguchi, S. Nagao, K. Itoh, T. Watanabe and S. Miura. 2006. Propionibacterium freudenreichii component 1.4-dihydroxy-2-naphthoic acid (DHNA) attenuates dextran sodium sulphate induced colitis by modulation of bacterial fl ora and lymphocyte homing. Gut 55: 681-688.
91. Oksaharju, A., T. Kooistra, R. Kleemann, D.W. van, M. Miettinen, J. Lappalainen, K.A. Lindstedt, P.T. Kovanen, R. Korpela and R.A. Kekkonen. 2012. Effects of probiotic Lactobacillus rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS supplementation on intestinal and systemic markers of infl ammation in ApoE 3Leiden mice consuming a high-fat diet. Br. J. Nutr. 1-9.
92. Orla-Jensen, O. 1909. Die hauptlinien des natürlichen bakteriensystems. Zentralbl. Bakteriol. 22: 305-346.
93. Oshio, S., I. Tahata and H. Minato. 1987. Effects of diets differing in ratios of roughage to concentrate on microfl ora in the rumen of heifers. J. Gen. Appl. Microbiol. 33: 99-100.
94. Ouwehand, A. C., H. Lagstrom, T. Suomalainen and S. Salminen. 2002. Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly. Annals of Nutrition and Metabolism 46: 159-162.
95. Parizzi, L.P., M.C. Grassi, L.A. Llerena, M.F. Carazzolle, V.L. Queiroz, I. Lunardi, A.F. Zeidler, P. J. Teixeira, P. Mieczkowski, J. Rincones and G. A. Pereira. 2012. The genome sequence of Propionibacterium acidipropionici provides insights into its biotechnological and industrial potential. BMC. Genomics 13: 562.
96. Perez Chaia, A., M.E.N. de Macias and G. Oliver. 1995. Propionibacteria in the gut: Effect on some metabolic activities of the host. Lait 75: 435-445.
97. Perez Chaia, A., G. Zarate and G. Oliver. 1999. The probiotic properties of propionibacteria. Lait 79: 175-185.
98. Piao, Y., M. Yamashita, N. Kawaraichi, R. Asegawa, H. Ono and Y. Murooka. 2004. Production of vitamin B12 in genetically engineered Propionibacterium freudenreichii. J. Biosci. Bioeng. 98: 167-173.
99. Piveteau, P. 1999. Metabolism of lactate and sugars by dairy propionibacteria: A review. Lait 79: 23-41.
100. Quesada-Chanto, A., A.S. Afschar and F. Wagner. 1994. Microbial production of propionic acid and vitamin B12 using molasses or sugar. Applied Microbiology and Biotechnology 41: 378-383.
101. Rainio, A., M. Vahvaselka, T. Suomalainen and S. Laakso. 2001. Reduction of linoleic acid inhibition in production of conjugated linoleic acid by Propionibacterium freudenreichii ssp. shermanii. Can. J. Microbiol. 47: 735-740.
102. Riedel, K.H., B.D. Wingfi eld and T. J. Britz. 1998. Identifi cation of classical Propionibacterium species using 16S rDNA-restriction fragment length polymorphisms. Syst. Appl. Microbiol. 21: 419-428.
103. Rinta-Koski, M., S. Beasley, L. Montonen and S. Mantere-Alhonen. 2001. Propionibacteria isolated from rumen used as possible probiotics together with bifidobacteria. Milchwissenschaft-Milk Science International 56: 11-13.
104. Roland, N., D. Bougle, F. Lebeurrier, P. Arhan and J.L. Maubois. 1998. Propionibacterium freudenreichii stimulates the growth of Bifi dobacterium bifi dum in vitro and increases fecal bifi dobacteria in healthy human volunteers. Int. Dairy Journal 8: 587-588.
105. Rolin, D.B., F. Girard, J.D. de Certaines and P. Boyaval. 1995. 13C-NMR study of lactate metabolism in Propionibacterium freudenreichii subsp. shermani. Appl. Microbiol. Biotechnol. 44: 210-217.
106. Rossi, F., S. Torriani and F. Dellaglio. 1998. Identifi cation and clustering of dairy propionibacteria by RAPD-PCR and CGE-REA methods. J. Appl. Microbiol. 85: 956-964.
107. Rossi, F., S. Torriani and F. Dellaglio. 1999. Genus- and species-specifi c PCR-based detection of dairy propionibacteria in environmental samples by using primers targeted to the genes encoding 16S rRNA. Appl. Environ. Microbiol. 65: 4241-4244.
108. Sarkar, S. and A.K. Misra. 1998. Effect of feeding propiono-acido-bifi do (PAB) milk on the nutritional status and excretory pattern in rats and infants. Milchwissenschaft 53: 666-668.
109. Sarkar, S. and A.K. Misra. 2002. Effect of feeding dietetic yoghurt on the nutritional status and excretory pattern in rats and infants. Egypt. J. Dairy Sci. 30: 63-73.
110. Satomi, K., H. Kurihara, K. Isawa, H. Mori and T. Kaneko. 1999. Effects of culture-powder of Propionibacterium freudenreichii ET-3 on fecal microfl ora of normal adults. Biosci. Microfl. 18: 27-30.
111. Sauer, F.D., J.K. Kramer and W.J. Cantwell. 1989. Antiketogenic effects of monensin in early lactation. J. Dairy Sci. 72: 436-442.
112. Saxelin, M., A. Lassig, H. Karjalainen, S. Tynkkynen, A. Surakka, H. Vapaatalo, S. Järvenpää, R. Korpela, M. Mutanen and K. Hatakka. 2010. Persistence of probiotic strains in the gastrointestinal tract when administered as capsules, yoghurt, or cheese. Int. J. Food Microbiol. 144: 293-300.
113. Seki, K., H. Nakao, H. Umino, H. Isshiki, N. Yoda, R. Tachihara, T. Ohuchi, H. Saruta, K. Suzuki and T. Mitsuoka. 2004. Effects of fermented milk whey containing novel bifi dogenic growth stimulator produced by Propionibacterium on fecal bacteria, putrefactive metabolite, defecation frequency and fecal properties in senile volunteers needed serious nursing-care taking enteral nutrition by tube feeding. J. Intest. Microbiol. 18: 107-115.
114. Seufferheld, M.J., H.M. Alvarez and M.E. Farias. 2008. Role of polyphosphates in microbial adaptation to extreme environments. Appl. Environ. Microbiol. 74: 5867-5874.
115. Somkuti, G.A. and T.L. Johnson. 1990. Cholesterol uptake by Propionibacterium freudenreichii. Curr. Microbiol. 20: 305-309.
116. Stackebrandt, E., P. Schumann, K.P. Schaal and N. Weiss. 2002. Propionimicrobium gen. nov., a new genus to accommodate Propionibacterium lymphophilum (Torrey 1916) Johnson and Cummins 1972, 1057(AL) as Propionimicrobium lymphophilum comb. nov. International Journal of Systematic and Evolutionary Microbiology 52: 1925-1927.
117. Suomalainen, T., P. Sigvart-Mattila, J. Matto and S. Tynkkynen. 2008. In vitro and in vivo gastrointestinal survival, antibiotic susceptibility and genetic identifi cation of Propionibacterium freudenreichii ssp. shermanii JS. Int. Dairy Journal 18: 271-278.
118. Thierry, A., M.B. Maillard, P. Bonnarme and E. Roussel. 2005. The addition of Propionibacterium freudenreichii to raclette cheese induces biochemical changes and enhances flavor development. Journalof Agricultural and Food Chemistry 53: 4157-4165.
119. Thierry, A., M.B. Maillard, C. Hervé, R. Richoux and S. Lortal. 2004a. Varied volatile compounds are produced by Propionibacterium freudenreichii in Emmental cheese. Food Chem. 87: 439-446.
120. Thierry, A., M.B. Maillard and M. Yvon. 2002. Conversion of L-leucine to isovaleric acid by Propionibacterium freudenreichii TL 34 and ITGP23. Appl. Environ. Microbiol. 68: 608-615.
121. Thierry, A., R. Richoux and J.R. Kerjean. 2004b. Isovaleric acid is mainly produced by Propionibacterium freudenreichii in Swiss cheese. Int. Dairy Journal 14: 801-807.
122. Trinidad, T.P., T.M.S. Wolever and L.U. Thompson. 1999. Effects of calcium concentration, acetate, and propionate on calcium absorption in the human distal colon. Nutrition 15: 529-533.
123. Uchida, M. and O. Mogami. 2005. Milk whey culture with Propionibacterium freudenreichii ET-3 is effective on the colitis induced by 2,4,6-trinitrobenzene sulfonic acid in rats. J. Pharmacol. Sci. 99: 329-334.
124. Viljanen, M., M. Kuitunen, T. Haahtela, K. Juntunen-Backman, R. Korpela and E. Savilahti. 2005a. Probiotic effects on faecal infl ammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants. Pediatr. Allergy Immunol. 16: 65-71.
125. Viljanen, M., E. Pohjavuori, T. Haahtela, R. Korpela, M. Kuitunen, A. Sarnesto, O. Vaarala and E. Savilahti. 2005b. Induction of infl ammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome. J. Allergy Clin. Immunol. 115: 1254-1259.
126. von Freudenreich, E. and O. Orla-Jensen. 1906. Uber die in Emmentalerkäse stattfi ndene Propionsäure-gärung. Zentralbl. Bakteriol. 17: 529-546.
127. Vorobjeva, L., P. Leverrier, A. Zinchenko, P. Boyaval, E. Khodjaev, S. Varioukhina, G. Ponomareva, E. Gordeeva and G. Jan. 2004. Anti-stress activity of Propionibacterium freudenreichii: identifi cation of a reactivative protein. Anton. Leeuw. Int. J. G. 85: 53-62.
128. Vorobjeva, L.I., T.A. Cherdinceva and S.K. Abilev. 1995. Antimutagenic action of bacteria on mutagenesis induced by 4-Nitroquinoline-1-oxide in Salmonella typhimurium. Microbiology 64: 187-192.
129. Vorobjeva, L.I., O.V. Iljasova, E. Khodjaev, G.M. Ponomareva and S. Varioukhina. 2001. Inhibition of induced mutagenesis in Salmonella typhimurium by the protein of Propionibacterium freudenreichii subsp. shermanii. Anaerobe 7: 37-44.
130. Wahle, K.W., S.D. Heys and D. Rotondo. 2004. Conjugated linoleic acids: are they benefi cial or detrimental to health? Prog. Lipid Res. 43: 553-587.
131. Wood, H.G. 1981. Metabolic cycles in the fermentation of propionic acid bacteria. In Current topics in cellular regulation, R.W. Eastbrook and P. Srera [eds.]. New York: Academic press, pp. 255-287.
132. Wood, H.G. and N.H. Goss. 1985. Phosphorylation enzymes of the propionic acid bacteria and the roles of ATP inorganic pyrophosphate, and polyphosphates. Proc. Natl. Acad. Sci. USA 82: 312-315.
133. Xu, S., T.D. Boylston and B.A. Glatz. 2005. Conjugated linoleic acid content and organoleptic attributes of fermented milk products produced with probiotic bacteria. J. Agric. Food Chem. 53: 9064-9072.
134. Yamazaki, S., K. Kano, T. Ikeda, K. Isawa and T. Kaneko. 1999. Role of 2-amino-3-carboxy-1,4- naphthoquinone, a strong growth stimulator for bifi dobacteria, as an electron transfer mediator for NAD(P)(+) regeneration in Bifi dobacterium longum. Biochim. Biophys. Acta 1428: 241-250.
135. Yokota, A., T. Tamura, M. Takeuchi, N. Weiss and E. Stackebrandt. 1994. Transfer of Propionibacterium innocuum Pitcher and Collins 1991 to Propioniferax gen. nov., as Propioniferax innocua comb. nov. Int. J. Syst. Bacteriol. 44: 579-582.
136. Zarate, G., A.P. Chaia, S. Gonzalez and G. Oliver. 2000. Viability and beta-galactosidase activity of dairy propionibacteria subjected to digestion by artifi cial gastric and intestinal fl uids. J. Food Prot. 63: 1214-1221.
137. Zarate, G., A.P. Chaia and G. Oliver. 2002. Some characteristics of practical relevance of the beta-galactosidase from potential probiotic strains of Propionibacterium acidipropionici. Anaerobe 8: 259-267.